Requirement of E7 oncoprotein for viability of HeLa cells
- 30 April 2006
- journal article
- Published by Elsevier BV in Microbes and Infection
- Vol. 8 (4), 984-993
- https://doi.org/10.1016/j.micinf.2005.10.015
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 50 references indexed in Scilit:
- Mechanisms of Human Papillomavirus-Induced OncogenesisJournal of Virology, 2004
- Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cellsThe FASEB Journal, 2002
- Biological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene, 2001
- Myc activates telomeraseGenes & Development, 1998
- The biology of replicative senescenceEuropean Journal Of Cancer, 1997
- Telomerase activation by the E6 gene product of human papillomavirus type 16Nature, 1996
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- Growth Dependence of Human Papillomavirus 16 DNA‐positive Cervical Cancer Cell Lines and Human Papillomavirus 16‐Transformed Human and Rat Cells on the Viral OncoproteinsJapanese Journal of Cancer Research, 1993
- The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene ProductScience, 1989